K.J. Harrison & Partners Inc lifted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 275.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,800 shares of the exchange traded fund’s stock after purchasing an additional 16,000 shares during the quarter. K.J. Harrison & Partners Inc’s holdings in SPDR S&P Biotech ETF were worth $2,236,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Capital A Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth about $26,000. Johnson Financial Group Inc. bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $31,000. Twin Peaks Wealth Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $32,000. Davis Capital Management acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA XBI opened at $128.28 on Thursday. The business has a fifty day moving average price of $125.02 and a two-hundred day moving average price of $112.14. The stock has a market capitalization of $8.57 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $132.09.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- REVEALED: Something Big Happening Behind White House Doors
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Read this or regret it forever
- Unlocked: Elon Musk’s Next Big IPO
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
